Page last updated: 2024-10-24
cetylpyridinium and Infections, Coronavirus
cetylpyridinium has been researched along with Infections, Coronavirus in 1 studies
Cetylpyridinium: Cationic bactericidal surfactant used as a topical antiseptic for skin, wounds, mucous membranes, instruments, etc.; and also as a component in mouthwash and lozenges.
Research Excerpts
| Excerpt | Relevance | Reference |
|---|
| "Prior influenza vaccination had no effect on study outcome." | 2.84 | Randomized, double-blind, placebo-controlled clinical trial to assess the safety and effectiveness of a novel dual-action oral topical formulation against upper respiratory infections. ( Adkins, I; Arters, K; Buchheit, K; Esper, F; Ghannoum, MA; Mukherjee, PK; Salata, RA, 2017) |
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Mukherjee, PK | 1 |
| Esper, F | 1 |
| Buchheit, K | 1 |
| Arters, K | 1 |
| Adkins, I | 1 |
| Ghannoum, MA | 1 |
| Salata, RA | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| A Pilot Study of the Safety, Tolerability, and Effectiveness of Halo to Prevent Acute Upper Respiratory Disease and Respiratory Virus Infections[NCT02644135] | | 100 participants (Actual) | Interventional | 2013-01-31 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trial Outcomes
Number of Acute Respiratory Illnesses
Measured by medical record review. (NCT02644135)
Timeframe: Through study duration, an average of 3 months
| Intervention | Number of acute respiratory illnesses (Number) |
|---|
| Halo Oral Spray | 4 |
| Halo Placebo | 2 |
Number of Participants That Develop Acute Respiratory Illnesses When Using Halo vs Placebo
(NCT02644135)
Timeframe: Through study duration, an average of 3 months
| Intervention | participants (Number) |
|---|
| Halo Oral Spray | 2 |
| Halo Placebo | 4 |
Trials
1 trial available for cetylpyridinium and Infections, Coronavirus